OSR Conference 2026 will take place at Mövenpick Hotel & Apartments Ghala Muscat from 17–19 December. Organised by the Oman Society of Rheumatology, the meeting brings adult and paediatric rheumatology together in a programme focused on diagnosis, management and multidisciplinary care.
The scientific agenda explores the boundaries between rheumatology and other specialties. Sessions examine inflammatory bowel disease in patients with spondylarthritis, eye disease, skin manifestations, neurological involvement and malignancy. This cross-specialty approach is complemented by discussions of systemic lupus erythematosus, Takayasu vasculitis, connective tissue disease-associated interstitial lung disease and Behçet’s disease.
A parallel paediatric rheumatology programme on Friday 18 December addresses hyperinflammatory syndromes, including haemophagocytic lymphohistiocytosis, inborn errors of immunity and the distinction between macrophage activation syndrome, sepsis and multisystem inflammatory syndrome in children. Further sessions consider monogenic vasculitis, challenging diagnostic cases, renal presentations, interferonopathies, genetic disorders and non-inflammatory causes of apparent myositis.
The final day brings adult and paediatric perspectives together. Topics include management of juvenile idiopathic arthritis, the direction of lupus treatment, genetic investigations when inborn errors of immunity are suspected, immune dysregulation in connective tissue disease, and the relationship between macrophage activation syndrome and cytokine storm syndrome.
Published contributors include Prof Laurent Arnaud, Prof Ömer Karadağ and Prof A.V. Ramanan. The agenda also includes clinicians from Oman and the wider region, with presentations by Dr Ikram Nasr, Dr Majid Al Shaaibi, Dr Rajaie Namas and paediatric specialists addressing the practical recognition and management of complex inflammatory disease.
Lectures are interspersed with questions and answers, poster viewing and industry symposia. The meeting offers rheumatologists and colleagues in related disciplines a setting to compare diagnostic approaches and discuss the implications of emerging therapies for adult and childhood disease. The published scientific agenda is dated 26 October 2026 and remains subject to change.
Abstract submissions close on 15 November 2026. Online registration closes on 8 December 2026. The current conference agenda is attached; published sessions remain subject to organiser changes. The society’s older registration fee table is for 2024 and does not establish current 2026 fees.
